Stereotaxis, Inc. (STXS)
Company Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room.
In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters.
Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components.
It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures.
Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Country | United States |
Founded | 1990 |
IPO Date | Aug 12, 2004 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 122 |
CEO | Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. |
Contact Details
Address: 710 N Tucker Blvd, Ste 110 St.louis, Missouri 63101 United States | |
Phone | 314-678-6100 |
Website | stereotaxis.com |
Stock Details
Ticker Symbol | STXS |
Exchange | NYSEAMERICAN |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001289340 |
CUSIP Number | 85916J409 |
ISIN Number | US85916J4094 |
Employer ID | 94-3120386 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. | Chief Executive Officer and Chairman |
Kimberly R. Peery | Chief Financial Officer and Secretary |
Keith Galloway | Vice President of Operations |
Laura Spencer Garth | General Counsel and Secretary |
Guy Judkowski | Equity Portfolio Manager |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 8, 2024 | 10-K | Annual Report |
Mar 4, 2024 | 8-K | Current Report |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 13, 2023 | 10-Q | Quarterly Report |
Nov 9, 2023 | 8-K | Current Report |
Aug 11, 2023 | 10-Q | Quarterly Report |
Aug 10, 2023 | 8-K | Current Report |
Jun 15, 2023 | 8-K | Current Report |
Jun 6, 2023 | EFFECT | Notice of Effectiveness |
Jun 6, 2023 | EFFECT | Notice of Effectiveness |